News Sentiment

DMYD-B sentiment intelligence

Diamyd Medical AB (publ) news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 50 Balanced news tone 1 relevant articles
Exchange STO Sweden
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 1.14 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

72/100 classification confidence.

Company focus 1

directly relevant article

Source quality 0

high-authority source matches

Trend context Trend inactive

+4.2% over one week, -1.2% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Diamyd Medical AB: Diamyd Medical's rights issue has been preliminarily subscribed to 95 percent, thereby raising approximately SEK 198 million

Market Reaction

Price moving ahead of tone

55/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 72/100 classification
One-week reaction 4.2% Price confirming higher
Trend fit Trend inactive -1.2% over four weeks
Fair value -89.3% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 1
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 1
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Finansavisen 1

Event Lens

What the news is about

Classified themes
Market update 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-1 of 1